Suzanne Nora Johnson is a distinguished figure in the world of finance and corporate governance, currently serving as the Chair of the Audit Committee at Pfizer Inc. She retired as Vice Chairman of Goldman Sachs in 2007, after a remarkable career spanning over two decades at the firm. At Goldman Sachs, she was instrumental in shaping the firm's strategic direction and played a key role in its growth and success. Her leadership and expertise in financial services earned her widespread recognition and respect within the industry.

As an independent board member at Pfizer, Johnson brings her extensive experience in business leadership and operations, finance and accounting, and risk management to the company. She chairs the Audit Committee and is also a member of the Regulatory and Compliance Committee, where she leverages her deep understanding of international business and healthcare and pharmaceuticals to guide the company's decision-making processes. Her contributions have been vital in ensuring Pfizer's adherence to the highest standards of corporate governance and financial integrity.

Johnson's professional achievements extend beyond her roles at Goldman Sachs and Pfizer. She has served on the boards of several other prominent organizations, including the University of Southern California and the American Red Cross. Her commitment to public service and philanthropy is evident in her involvement with various charitable initiatives and her efforts to promote education and healthcare access. Johnson's diverse skill set, combined with her unwavering dedication to excellence, make her an invaluable asset to Pfizer and the broader business community.